TGFB1 and neoplasm: In addition to the risk of surgery- and radiation-induced tumor metastasis, an anti-cancer drug doxorubicin, which intercalates into DNA and inhibits DNA topoisomerase II, has been reported to stimulate metastasis and invasion of tumor cells via transforming growth factor-β (TGF-β) signaling in breast cancer cells [3,6].